NASDAQ:ALECAlector Stock Price, Forecast & News

Alector's stock was trading at $24.92 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ALEC shares have decreased by 1.9% and is now trading at $24.44. View which stocks have been most impacted by Coronavirus.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alector in the last year. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Alector.

Alector is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020. View our earnings forecast for Alector.

Alector Inc (NASDAQ:ALEC) posted its quarterly earnings data on Wednesday, May, 13th. The company reported ($0.53) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.43) by $0.10. The business had revenue of $7.17 million for the quarter, compared to the consensus estimate of $10.60 million. Alector had a negative return on equity of 48.29% and a negative net margin of 556.70%. View Alector's earnings history.

8 equities research analysts have issued twelve-month price objectives for Alector's stock. Their forecasts range from $28.00 to $41.00. On average, they expect Alector's stock price to reach $33.00 in the next year. This suggests a possible upside of 35.0% from the stock's current price. View analysts' price targets for Alector.

Media headlines about ALEC stock have been trending very negative on Thursday, according to InfoTrie. The research group scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Alector earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about Alector.

Some companies that are related to Alector include Repligen (RGEN), Adaptive Biotechnologies (ADPT), Allogene Therapeutics (ALLO), Acceleron Pharma (XLRN), Novavax (NVAX), Crispr Therapeutics (CRSP), Spark Therapeutics (ONCE), China Biologic Products (CBPO), Momenta Pharmaceuticals (MNTA), Ablynx (ABLYF), Halozyme Therapeutics (HALO), Iovance Biotherapeutics (IOVA), bluebird bio (BLUE), Fate Therapeutics (FATE) and Denali Therapeutics (DNLI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Alector investors own include Editas Medicine (EDIT), NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Gossamer Bio (GOSS), Cisco Systems (CSCO), Harpoon Therapeutics (HARP), Johnson & Johnson (JNJ), Kaleido Biosciences (KLDO) and AT&T (T).

(ALEC) raised $177 million in an initial public offering on Thursday, February 7th 2019. The company issued 9,300,000 shares at $18.00-$20.00 per share. Morgan Stanley, BofA Merrill Lynch, Cowen and Barclays acted as the underwriters for the IPO.

Alector trades on the NASDAQ under the ticker symbol "ALEC."

Shares of ALEC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ALEC stock can currently be purchased for approximately $24.44.

Alector has a market capitalization of $1.93 billion and generates $21.22 million in revenue each year. The company earns $-105,390,000.00 in net income (profit) each year or ($1.71) on an earnings per share basis. Alector employs 91 workers across the globe.

The official website for Alector is www.alector.com.

Alector's mailing address is 131 OYSTER POINT BLVD. SUITE 600, SOUTH SAN FRANCISCO CA, 94080. The company can be reached via phone at 415-231-5660 or via email at [email protected]